Blue Box Biomedical Solutions Inc. - Startup Battlefield Disrupt 2021
The Blue Box: A Novel Approach to Breast Cancer Detection
This information was documented on September 22, 2021. The Blue Box represents a groundbreaking medical device currently in development.
Its design is inspired by the highly sensitive olfactory system found in canines, specifically mimicking the function of olfactory neurons.
Core Functionality and Design Principles
The Blue Box is an AI-powered device intended for at-home breast cancer testing. It aims to provide a non-invasive, non-irradiating, and affordable method for detection.
A key goal of the project is to create a testing process that is both highly specific and easy for individuals to use.
The Testing Process
The device operates through a remarkably simple procedure: analysis of a urine sample. The entire process is contained within a compact unit – the “BOX” itself.
This innovative approach seeks to revolutionize breast cancer screening by offering a convenient and accessible alternative to traditional methods.
Key Advantages of The Blue Box
- Non-Invasive: The test does not require any physically intrusive procedures.
- Non-Irradiating: It avoids the use of radiation, minimizing potential health risks.
- Inexpensive: The device is being developed with cost-effectiveness as a primary consideration.
- Specific: The AI is designed to identify biomarkers associated with breast cancer with high accuracy.
- User-Friendly: The testing process is intended to be simple and straightforward for individuals to perform at home.
The Blue Box holds significant promise as a future tool for early breast cancer detection, potentially improving outcomes through timely diagnosis.